Bremer Bank National Association’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,209
| Closed | -$406K | – | 216 |
|
|
2021
Q2 | $406K | Sell |
2,209
-8,253
| -79% | -$1.52M | 0.09% | 143 |
|
|
2021
Q1 | $1.6M | Sell |
10,462
-7,127
| -41% | -$1.09M | 0.37% | 78 |
|
|
2020
Q4 | $2.75M | Sell |
17,589
-243
| -1% | -$38K | 0.66% | 46 |
|
|
2020
Q3 | $2.04M | Sell |
17,832
-1,092
| -6% | -$125K | 0.54% | 58 |
|
|
2020
Q2 | $2.12M | Sell |
18,924
-606
| -3% | -$68K | 0.6% | 49 |
|
|
2020
Q1 | $1.75M | Buy |
19,530
+230
| +1% | +$20.7K | 0.5% | 59 |
|
|
2019
Q4 | $2.09M | Sell |
19,300
-163
| -0.8% | -$17.6K | 0.45% | 66 |
|
|
2019
Q3 | $1.91M | Sell |
19,463
-84
| -0.4% | -$8.23K | 0.42% | 71 |
|
|
2019
Q2 | $2.56M | Buy |
19,547
+539
| +3% | +$70.6K | 0.55% | 49 |
|
|
2019
Q1 | $2.59M | Buy |
+19,008
| New | +$2.59M | 0.51% | 49 |
|